The Science Behind "California Sober"

The first randomized, placebo-controlled clinical trial on cannabis and alcohol substitution was published in November 2025, and the results were straightforward: participants who smoked cannabis drank 19% to 27% less alcohol than those who received a placebo.

The Brown University study, published in the American Journal of Psychiatry, enrolled 157 adults who used both alcohol and cannabis regularly. Across three lab sessions, participants smoked cannabis with varying THC levels — 3.1%, 7.2%, or a placebo — then entered a room designed to look like a bar, where they could choose to drink their preferred alcoholic beverage or earn small cash payments for each drink they declined.

Cannabis didn't just reduce how much people drank. It reduced the immediate urge to drink and delayed how long participants waited before taking their first sip. "Instead of seeing cannabis increase craving and drinking, we saw the opposite," said lead researcher Jane Metrik, a professor at Brown's School of Public Health.

Here's the honest part: the researchers themselves said this doesn't mean you should swap one substance for another without thinking. Cannabis carries its own risks, including the potential for dependence. This was a short-term lab study, and we don't yet know whether the same effect holds up over months or years of real-world use. But it's the first rigorous evidence that the substitution effect people have been reporting anecdotally — the thing called "California sober" — has a measurable biological basis.

Why So Many People Are Reconsidering Alcohol

The conversation around alcohol has shifted dramatically, and it's not driven by trends alone. In January 2025, the U.S. Surgeon General issued an advisory linking alcohol consumption to at least seven types of cancer — breast, colorectal, esophageal, liver, mouth, throat, and larynx. Alcohol is now recognized as the third leading preventable cause of cancer in the United States, responsible for roughly 100,000 cancer cases and 20,000 cancer deaths annually.

Less than half of Americans were aware of this link before the advisory. That's changing quickly.

Meanwhile, participation in Dry January keeps climbing. A 2026 CivicScience survey found 56% of American drinkers were at least somewhat likely to abstain for the month, up from 52% in 2024. And the definition of "dry" is evolving — 17% of Dry January participants reported choosing cannabis beverages or other cannabis products as their substitute for alcohol, matching the percentage who chose mocktails or non-alcoholic beer.

This isn't just a January phenomenon. Nearly half of Gen Z adults identify as "sober curious," and 65% planned to drink less in 2025. Cannabis beverage sales consistently spike each January — wholesale cannabis beverage orders rose 5.4% year-over-year in January 2025, according to LeafLink market data, following even larger increases in previous years.

The pattern is clear: Americans aren't just drinking less. They're actively choosing alternatives. And cannabis is the one gaining the most ground.

Cannabis vs. Alcohol: An Honest Comparison

Let's be direct about what cannabis does and doesn't offer compared to alcohol. This isn't a sales pitch — it's a side-by-side look at what we actually know.

What cannabis avoids. No hangover. No liver toxicity. No caloric load from sugar and ethanol. No classification as a Group 1 carcinogen by the World Health Organization. Alcohol's connection to seven cancers is established science. Cannabis has no comparable cancer link.

What cannabis doesn't avoid. Impairment — cannabis affects coordination, reaction time, and judgment, especially at higher doses. Dependence — roughly 9% of regular cannabis users develop cannabis use disorder, compared to about 15% for alcohol, but the risk is real. Cardiovascular concerns — some research links heavy cannabis use to elevated heart attack and stroke risk, though this data is far less established than alcohol's cancer connection. Cognitive effects — regular heavy use can affect memory and attention, particularly in younger adults.

Where cannabis genuinely differs. The therapeutic window is wider with low-dose products. A 2.5mg or 5mg edible provides mild relaxation without significant impairment. That kind of precision doesn't exist with alcohol, where the distance between "relaxed" and "impaired" is narrow and different for every person.

The morning after matters too. Anyone who has woken up after a few drinks versus a low-dose edible the night before understands the difference. The science supports what people already know from experience — alcohol disrupts sleep architecture, particularly REM sleep, while low-dose cannabis, especially varietals higher in CBD or the terpene myrcene, may not carry the same penalty. (We wrote about this in detail in our cannabis and sleep guide.)

Low-Dose Products: A Practical Guide for Vermont

Vermont's regulated cannabis market offers several product categories suited for people exploring cannabis as an alcohol alternative. Here's what to know about each.

Cannabis beverages. Vermont dispensaries carry THC-infused seltzers and teas, including products from Vermont-based producers. These are the closest analog to a social drink — you sip them, they come in familiar formats, and the onset is faster than traditional edibles, typically 15 to 30 minutes versus 60 to 90 for baked goods. Vermont cannabis beverages must comply with the state's 5mg THC per serving limit, which is actually ideal for this kind of measured use.

Low-dose edibles. Vermont law caps edibles at 5mg THC per serving and 50mg per package. For someone replacing a glass of wine, a single 2.5mg or 5mg gummy provides mild, manageable effects. Start with half a serving if you're new to edibles. The most common mistake — by far — is taking a second dose before the first one peaks. Edibles can take up to two hours to reach full effect. We cover this in depth in our edibles dosing guide.

Tinctures. These offer the most precise dosing control. A dropper lets you measure exactly where you want to be. Sublingual absorption — held under the tongue for 30 to 60 seconds — produces effects in 15 to 30 minutes, faster than swallowed edibles. Tinctures are discreet and don't carry the social signaling of smoking or vaping.

Flower and pre-rolls. Inhalation provides the fastest onset — effects within minutes — and the shortest duration, typically one to three hours. For someone accustomed to the social ritual of drinking, sharing a pre-roll can fill a similar role. At Sunkissed Farm, our pre-rolls use whole flower, never shake, and our in-house varietals offer a range of experiences from calm relaxation to gentle creative energy. If you're looking for something uplifting for a social evening, our terpene guide to energy and focus is a good place to start.